DalsnaFinance › IPOs › Acumen Pharmaceuticals › IPO
Acumen Pharmaceuticals, Inc. completed its initial public offering on NASDAQ on July 1, 2021, pricing at $16.00 a share.
| Ticker | ABOS |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | July 1, 2021 |
| Offering price | $16.00 |
| Shares offered | 9,999,999 |
| Total raised | $160M |
Acumen Pharmaceuticals, Inc. sold 9,999,999 shares at $16.00 each on NASDAQ. Multiplied out, that is $160 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $160 million total recorded for the deal.
Acumen Pharmaceuticals, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Acumen Pharmaceuticals, Inc.. This page is general information, not investment advice.